Mayo Clinic: Less Invasive Surgery Detects Residual Breast Cancer in Lymph Nodes after Chemotherapy
By Health Canal | December 7, 2012 11:37 AM EST
Most patients whose breast cancer has spread to their lymph nodes have most of the lymph nodes in their armpit area removed after chemotherapy to see if any cancer remains.
A study conducted through the American College of Surgeons Oncology Group and led by Judy Boughey, M.D. a breast surgeon at Mayo Clinic shows that a less invasive procedure known as sentinel lymph node surgery successfully identified whether cancer remained in lymph nodes in 91 percent of patients with node-positive breast cancer who received chemotherapy before their surgery. In sentinel lymph node surgery, only a few lymph nodes, the ones most likely to contain cancer, are removed. The findings are being presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium.
MULTIMEDIA ALERT: Animation and a video interview with Dr. Boughey are available for journalists to download on the Mayo Clinic News Network.
"Since treatment with chemotherapy before surgery can eliminate cancer in the lymph nodes in some patients, we were interested in evaluating whether sentinel lymph node surgery could successfully identify whether cancer remained in the lymph nodes after chemotherapy," says Dr. Boughey. Removing only a few lymph nodes reduces the risk of surgical complications such as numbness and arm swelling, she says.
Researchers studied 756 women with node-positive breast cancer who received chemotherapy as an initial treatment. Of study participants, 637 patients had both sentinel lymph node and axillary lymph node surgery. Sentinel lymph node surgery correctly identified whether cancer lingered in 91 percent of patients, including 255 patients with node-negative breast cancer and 326 patients with continuing node-positive disease.
Researchers also found that 40 percent of the patients had complete eradication of the cancer from the lymph nodes. The study had a false-negative rate of 12.6 percent and the false negative rate was significantly lower with the use of dual tracers (blue dye and radiolabeled colloid) to identify the sentinel lymph nodes.
Dr. Boughey says that technical factors in surgery are important to help ensure correct staging, the process of determining how far cancer may have spread.
The study was conducted through the American College of Surgeons Oncology Group and funded by the National Cancer Institute.
To know more, visit Health Canal.
Most Popular Slideshows
Join the Conversation
- HIV Cure: Modified Gene Therapy Causing Resistance And Mysterious Enzyme Could Unlock Effective Treatment
- Using Hand Dryers in Public Restrooms Could Spread Germs
- Kourtney Kardashian Thinks Pregnancy Nausea Should Not Be Called 'Morning Sickness' Because It Lasts All Day
- Text Neck Causes More Harm Than You Think
- Kourtney Kardashian Shares Tips On How To Find A Good Pediatrician For Your Kids
- Russia's New Tactical Nuclear Weapons Program Growing Confident Against the US: Talks of World War III
- Apple and Google Engage in Thermonuclear War, New Google Translate Chat App in the Works
- Kobani ISIS Fighter Sends Out Desperate Message For Prayers And Support: Euphoria Turns Into Desperation As Kurds Advance
- Chris Algieri’s Battered Face Trends On Social Media
- Walmart Offers the Best 2014 Black Friday Deals on iPhone 6, iPad Ai2 & Other Gadgets – Reports
- Highest Paid NBA Players 2014: NBA Stars Who Earn More Than LeBron James
- Update Samsung Galaxy S5 to Android 4.4.4 KitKat, Sprint Release and Installation